Clinical Trial: Mass Balance Study of [14C]DA-302168S in Healthy Chinese Adult Male Participants

U.S., Oct. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07857265) titled 'Mass Balance Study of [14C]DA-302168S in Healthy Chinese Adult Male Participants' on Sept. 29.

Brief Summary: In this study, a single dose of [14C] radiolabelled DA-302168S will be administered orally. The main purpose of this study is to find out how much of DA-302168S and its metabolites pass from blood into urine and feces, and characterize the metabolic profile and routes of excretion of oral [14C] DA-302168S.

Study Start Date: Nov. 20

Study Type: INTERVENTIONAL

Condition: Healthy Adult Subjects

Intervention: DRUG: [14C] DA-302168S

Administered orally

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Chendu DIAO Pharmaceut...